Surmodics
SRDX
SRDX was delisted on the 18th of November, 2025.
105 hedge funds and large institutions have $385M invested in Surmodics in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 37 increasing their positions, 36 reducing their positions, and 21 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
35% more capital invested
Capital invested by funds: $286M → $385M (+$99M)
3% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 36
1.78% less ownership
Funds ownership: 88.85% → 87.07% (-1.8%)
12% less funds holding
Funds holding: 119 → 105 (-14)
67% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 21
96% less call options, than puts
Call options by funds: $85K | Put options by funds: $2.09M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$10.1M |
| 2 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$4.65M |
| 3 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$1.23M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.08M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$595K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.22M |
| 2 |
State Street
Boston,
Massachusetts
|
-$2.42M |
| 3 |
Goldman Sachs
New York
|
-$2.34M |
| 4 |
Jane Street
New York
|
-$2.06M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$1.44M |
SRDX Hedge Fund Activity: Q2 2023 in Review
105 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q2 2023, worth a combined $385M — up 35% from $286M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of SRDX and 7 opened new positions — a net loss of 14 holders — while 36 trimmed existing stakes and 37 added.
The largest buyer was Soleus Capital Management, adding an estimated $10.1M. The largest seller was Wellington Management Group, exiting entirely with an estimated $5.22M sold.
- 105 institutional investors held Surmodics (SRDX) as of Q2 2023, down from 119 in Q1 2023.
- Funds reported $385M of Surmodics stock for Q2 2023, up 35% quarter-over-quarter.
- 7 funds opened new Surmodics positions in Q2 2023 and 21 closed out, a net change of -14 holders.
- The largest Surmodics buyer in Q2 2023 was Soleus Capital Management, an estimated $10.1M added.
- The largest Surmodics seller in Q2 2023 was Wellington Management Group, an estimated $5.22M sold.
Based on aggregated 13F filings for Q2 2023.